Top Markets
#1 Black Phoenix Black Phoenix +861.87%
#2 QuantixAI QuantixAI +102.94%
#3 MetaDAO MetaDAO +25.00%
#4 Bedrock Bedrock +21.77%
#5 Ontology Gas Ontology Gas +21.61%
#6 Pons Pons +20.95%
#7 龙虾 (Lobster) 龙虾 (Lobster) +20.42%
#8 Siren Siren +20.12%
#9 SPX6900 SPX6900 +18.34%
#10 DOG•GO•TO•THE•MOON (Runes) DOG•GO•TO•THE•MOON (Runes) +16.35%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
Immunovant, Inc. Immunovant, Inc.

Immunovant, Inc.

IMVT
Rank in Stocks #2340
Immunovant, Inc. is a biopharmaceutical firm in the clinical development phase,... Immunovant, Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to advancing novel monoclonal antibody therapies for the treatment of various autoimmune conditions. The company's primary focus is batoclimab, a pioneering, fully human monoclonal antibody. This antibody is engineered to specifically target and block the neonatal fragment crystallizable receptor (FcRn), a key mechanism in certain autoimmune diseases. Batoclimab is currently undergoing Phase IIa clinical evaluations for treating both myasthenia gravis and thyroid eye disease. Additionally, it has commenced Phase II clinical studies for patients suffering from warm autoimmune hemolytic anemia. Established in 2018, Immunovant operates from its headquarters in New York, New York, functioning as a subsidiary under the umbrella of Roivant Sciences Ltd.
Share Price
$43.60
Market Cap
$9.00B
Change (1 day)
0.65%
Change (1 year)
192.84%
Country
US
Trade Immunovant, Inc. (IMVT)

Category

Healthcare
Stock price history for Immunovant, Inc. (IMVT)
Highest end of day price: $42.52 on 2026-08-01

Lowest end of day price: $9.88 on 2019-06-01
Stock price history of Immunovant, Inc. from 2019 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) 8.62%
2025 -7.38%
2024 -34.45%
2023 163.89%
2022 99.44%
2021 -84.02%
2020 273.47%
2019 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $555.05 42.71%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.02K 51.02%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $158.54 525.40%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $122.47 -12.71%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $772.27 8.67%
CH